Preclinical Evaluation of Allogeneic CD19 CAR T Cells Expressing an Anti-Rejection CD70 CAR Post author:andrewkaretas Post published:November 2, 2023 Post category:Dual/PLATFORM/Scientific Publications Continue ReadingPreclinical Evaluation of Allogeneic CD19 CAR T Cells Expressing an Anti-Rejection CD70 CAR
Generation of Immune-Evasive Allogeneic CAR T Cells by Inactivation of the HLA Transcriptional Regulator RFX5 and Disruption of the Immune Synapse Post author:andrewkaretas Post published:November 2, 2023 Post category:PLATFORM/Scientific Publications Continue ReadingGeneration of Immune-Evasive Allogeneic CAR T Cells by Inactivation of the HLA Transcriptional Regulator RFX5 and Disruption of the Immune Synapse
Selective Targeting of Host CD70+ Alloreactive Cells With a CD70 Dagger™ Receptor to Prolong Allogeneic CAR T Cell Persistence Post author:andrewkaretas Post published:February 18, 2023 Post category:PLATFORM/Scientific Publications Continue ReadingSelective Targeting of Host CD70+ Alloreactive Cells With a CD70 Dagger™ Receptor to Prolong Allogeneic CAR T Cell Persistence
Generation of Hypoimmunogenic Allogeneic CAR T Cells by Inactivation of Transcriptional Regulators of HLA Class I and II Genes Post author:andrewkaretas Post published:November 18, 2022 Post category:PLATFORM/Scientific Publications Continue ReadingGeneration of Hypoimmunogenic Allogeneic CAR T Cells by Inactivation of Transcriptional Regulators of HLA Class I and II Genes
Allogeneic CAR T Cells Derived From Younger Donor T Cells Have More Desirable T Cell Phenotype And Better in vitro Functionality Post author:andrewkaretas Post published:May 18, 2022 Post category:PLATFORM/Scientific Publications Continue ReadingAllogeneic CAR T Cells Derived From Younger Donor T Cells Have More Desirable T Cell Phenotype And Better in vitro Functionality
PD1 TurboCAR™ T Cells: PD1-Resistant CAR T Cells With Programmable Cytokine Signaling Outputs Post author:andrewkaretas Post published:April 18, 2021 Post category:PLATFORM/Scientific Publications Continue ReadingPD1 TurboCAR™ T Cells: PD1-Resistant CAR T Cells With Programmable Cytokine Signaling Outputs
American Association for Cancer Research (AACR) June 2020 – SMIC CAR T Cells: CAR T with Temporally-Controlled, Programmable Cytokine Signaling Outputs Post author:andrewkaretas Post published:June 18, 2020 Post category:PLATFORM/Scientific Publications Continue ReadingAmerican Association for Cancer Research (AACR) June 2020 – SMIC CAR T Cells: CAR T with Temporally-Controlled, Programmable Cytokine Signaling Outputs
American Society of Gene and Cell Therapy (ASGCT) May 2020 – TurboCAR™ T Cells: CAR T Cells with Constitutive, Programmable Cytokine Signaling Outputs Post author:andrewkaretas Post published:May 18, 2020 Post category:PLATFORM/Scientific Publications Continue ReadingAmerican Society of Gene and Cell Therapy (ASGCT) May 2020 – TurboCAR™ T Cells: CAR T Cells with Constitutive, Programmable Cytokine Signaling Outputs
Toward “Off-the-Shelf” Allogeneic CAR T Cells Post author:andrewkaretas Post published:April 18, 2020 Post category:PLATFORM/Scientific Publications Continue ReadingToward “Off-the-Shelf” Allogeneic CAR T Cells
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies Valton J, Guyot V, Boldajipour B, et al. Post author:andrewkaretas Post published:June 18, 2018 Post category:PLATFORM/Scientific Publications Scientific Reports Continue ReadingA Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies Valton J, Guyot V, Boldajipour B, et al.
